| Test | Case | Country/Region | Source |
| Sero-Screening, CT Scan | Neurocysticercosis | Nepal | [32] [33] |
| CT Scan, MRI and Biopsy | Multiple tonics-chronic seizures vs neurocysticercosis | United States of America | [34] |
| Sero-Screening | Epilepsy as indirect marker for neurocysticercosis | Laos, South-East Asia | [35] |
| Autopsy and Sero-Screening | Human cysticercosis | Central and West Africa | [22] |
| Sero-Screening, X-Ray and Autopsy | Human cysticercosis | Togo and Benin | [36] [37] |
| Sero-Screening and CT Scan | Human cysticercosis | Cameroon | [22] [38] |
| Sero-Screening | Human cysticercosis | Burundi | [39] -[41] |
| Sero-Screening, CT Scan and Autopsy | Human cysticercosis | Eastern and South Africa | [42] -[45] |
| X-Ray and Sero-Screening | Human cysticercosis | Zimbabwe | [46] -[48] |
| Sero-Screening | Human cysticercosis | Mozambique | [49] [50] |
| Sero-Screening | Human cysticercosis | Madagascar | [51] [52] |
| Sero-Screening | Human cysticercosis | Kenya | [53] |
| Serology and Cerebral Spinal Fluid (CSF)-Screening, CT Scan | Human cysticercosis/neurocysticercosis | Tanzania | [4] [5] [26] [27] |